Clinic
Good Samaritan Hospital
Good Samaritan Hospital was paid $9.76M by Medicaid between Jan 2018 and Dec 2024, across 184 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 18% of everything it billed.
33Billing provider infoGOOD SAMARITAN HOSPITAL
KEARNEY, NE 68847
KEARNEY, NE 68847
33aNPI1336184019assigned 06/18/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$9.76M
24GClaims255,821
24DCodes billed184
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Nebraska
Rank by total paid#5 of 35
Median peer was paid$190K
This provider vs. median51×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KUIPER, EVERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,893 | $1.48M | |
| 2019 | 29,493 | $1.24M | |
| 2020 | 26,420 | $1.18M | |
| 2021 | 65,919 | $2.28M | |
| 2022 | 69,762 | $2.06M | |
| 2023 | 30,561 | $1.07M | |
| 2024incomplete | 8,773 | $456K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 18% | 1,037 | 994 | $1.73M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 9,741 | 8,800 | $1.48M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 7,047 | 6,225 | $1.16M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.0% | 2,750 | 2,328 | $487K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.9% | 1,670 | 1,249 | $476K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.7% | 1,404 | 1,245 | $362K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.7% | 1,214 | 1,048 | $360K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3.0% | 1,039 | 996 | $291K |
| G0378 | Hospital observation service, per hour | 2.7% | 1,524 | 1,262 | $262K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.6% | 341 | 274 | $251K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.3% | 2,020 | 1,216 | $227K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.2% | 2,015 | 1,798 | $217K |
172 more codes
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2.2% | 990 | $212K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 2,056 | $161K |
| A0427 | Emergency ambulance ride, advanced life support | 1.6% | 1,249 | $156K |
| A0425 | Ground mileage, per statute mile | 1.6% | 4,394 | $155K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 1,379 | $119K |
| A0429 | Emergency ambulance ride, basic life support | 1.0% | 1,449 | $99K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 180 | $85K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 254 | $82K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 557 | $69K |
| 80053 | Comprehensive metabolic panel | <1% | 13,359 | $68K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,897 | $62K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,808 | $60K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,509 | $54K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 238 | $50K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,117 | $48K |
| J3490 | Unclassified drugs | <1% | 16,999 | $44K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 84 | $39K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,633 | $37K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 125 | $34K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,472 | $32K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,382 | $30K |
| 80050 | General health panel | <1% | 3,109 | $30K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,377 | $29K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 685 | $27K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 866 | $26K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,450 | $23K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 299 | $23K |
| 83880 | <1% | 1,782 | $20K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 937 | $20K |
| 87631 | <1% | 119 | $19K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,438 | $19K |
| 86140 | <1% | 5,042 | $19K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,133 | $18K |
| 84702 | <1% | 1,729 | $18K | |
| 84439 | <1% | 1,451 | $18K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 68 | $17K |
| 80061 | Lipid panel | <1% | 2,847 | $16K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,648 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 333 | $15K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,236 | $15K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,695 | $15K |
| 84145 | <1% | 2,347 | $15K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,840 | $14K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 30 | $14K |
| 94664 | <1% | 417 | $14K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 286 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,375 | $13K |
| 87077 | <1% | 1,717 | $11K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,002 | $10K |
| 87581 | <1% | 274 | $9K | |
| 86803 | <1% | 758 | $9K | |
| 83605 | <1% | 5,287 | $7K | |
| 87040 | <1% | 1,529 | $7K | |
| 80069 | <1% | 1,264 | $7K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 167 | $7K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,903 | $6K |
| 84484 | <1% | 3,704 | $6K | |
| 93017 | <1% | 16 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 99 | $6K |
| 81001 | <1% | 4,911 | $6K | |
| 83735 | <1% | 2,899 | $6K | |
| 85027 | <1% | 1,581 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 143 | $6K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 208 | $5K |
| 87070 | <1% | 620 | $5K | |
| 87081 | <1% | 521 | $5K | |
| 85610 | <1% | 3,864 | $5K | |
| 12001 | <1% | 14 | $5K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,521 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,865 | $5K |
| 86710 | <1% | 393 | $5K | |
| 83690 | <1% | 2,746 | $5K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 12 | $5K |
| 93971 | <1% | 24 | $4K | |
| 87480 | <1% | 485 | $4K | |
| 96376 | <1% | 1,180 | $4K | |
| 87400 | <1% | 327 | $4K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 27 | $4K |
| 85730 | <1% | 2,270 | $3K | |
| 87205 | <1% | 734 | $3K | |
| 82553 | <1% | 454 | $3K | |
| 0099U | <1% | 27 | $3K | |
| 87186 | <1% | 829 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,266 | $3K |
| 85652 | <1% | 1,158 | $3K | |
| 87430 | <1% | 198 | $3K | |
| 82962 | <1% | 2,696 | $3K | |
| 82550 | <1% | 669 | $3K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 15 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 198 | $3K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 8,770 | $3K |
| 87660 | <1% | 485 | $3K | |
| 86850 | <1% | 185 | $3K | |
| 74018 | <1% | 99 | $2K | |
| 82803 | <1% | 901 | $2K | |
| 0097U | <1% | 14 | $2K | |
| 86900 | <1% | 270 | $2K | |
| 97597 | <1% | 25 | $2K | |
| 97165 | <1% | 37 | $2K | |
| 82728 | <1% | 289 | $2K | |
| 87510 | <1% | 485 | $2K | |
| 71250 | <1% | 27 | $2K | |
| 97161 | <1% | 111 | $2K | |
| 87807 | <1% | 134 | $2K | |
| 82150 | <1% | 302 | $2K | |
| 84703 | <1% | 232 | $2K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 35 | $2K |
| 83550 | <1% | 203 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 182 | $1K |
| 83540 | <1% | 235 | $1K | |
| 85379 | <1% | 1,023 | $1K | |
| 82570 | <1% | 287 | $1K | |
| 80081 | <1% | 13 | $1K | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 14 | $957.86 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 833 | $849.86 |
| 87634 | <1% | 12 | $655.12 | |
| 84100 | <1% | 398 | $636.60 | |
| 81003 | <1% | 919 | $573.02 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 45 | $520.74 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 39 | $412.51 |
| 90715 | <1% | 16 | $397.40 | |
| 84156 | <1% | 179 | $396.58 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 222 | $389.48 |
| 84146 | <1% | 39 | $360.78 | |
| 97116 | <1% | 39 | $357.21 | |
| A9270 | Non-covered item or service | <1% | 2,424 | $350.30 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,759 | $330.86 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 43 | $308.02 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 850 | $299.35 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 684 | $291.25 |
| 82607 | <1% | 21 | $281.80 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 147 | $267.16 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 285 | $266.63 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 17 | $206.27 |
| 85018 | <1% | 33 | $201.14 | |
| 87147 | <1% | 41 | $200.26 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 14 | $195.44 |
| 80164 | <1% | 27 | $181.80 | |
| 86901 | <1% | 279 | $169.20 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 480 | $156.81 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,340 | $145.69 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 540 | $129.24 |
| 82784 | <1% | 12 | $93.48 | |
| 82248 | <1% | 15 | $87.60 | |
| 99152 | <1% | 69 | $86.69 | |
| 82077 | <1% | 673 | $83.95 | |
| 81025 | <1% | 1,096 | $78.81 | |
| 80143 | <1% | 271 | $55.49 | |
| 85007 | <1% | 17 | $51.29 | |
| 84550 | <1% | 13 | $44.48 | |
| 86364 | <1% | 13 | $42.25 | |
| 80179 | <1% | 267 | $28.11 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 119 | $16.60 |
| A4649 | Surgical supply; miscellaneous | <1% | 62 | $15.75 |
| 82800 | <1% | 408 | $11.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 27 | $10.76 |
| 99153 | Mod sedat endo service >5yrs | <1% | 17 | $9.64 |
| 81015 | <1% | 55 | $7.60 | |
| 94760 | <1% | 181 | $3.80 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,557 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 104 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 30 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 115 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 28 | $0.00 |
| C1769 | Guide wire | 0% | 112 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 147 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 205 | $0.00 |
| D1206 | Topical application of fluoride varnish | 0% | 12 | $0.00 |
| 94761 | 0% | 20 | $0.00 | |
| 84436 | 0% | 17 | $0.00 | |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 16 | $0.00 |
| D0272 | Bitewings - two radiographic images | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKUIPER, EVERT (CEO - CHI HEALTH)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.